INSULINREZEPTOR-BINDENDE ANTIKÖRPER

European patent · EP2957296 · In force

Register entry

Publication number
EP2957296
Application number
EP15174585
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 25, 2010
Published
Dec 23, 2015
Granted
May 1, 2019
Protection ends at the latest
Sep 24, 2030
Next annual fee due
Sep 30, 2027
IPC classes
A61K 39/395 (2006.01)
A61P 3/10 (2006.01)
C07K 16/26 (2006.01)
C07K 16/28 (2006.01)
Priority
US 246067 P 25.09.2009
US 306321 P 19.02.2010
US 358749 P 25.06.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. Oct 3, 2024

    Change

    Published in Swissreg on 03.10.2024

  4. Oct 2, 2023

    Change

    Published in Swissreg on 02.10.2023

  5. Oct 6, 2022

    Change

    Published in Swissreg on 06.10.2022

  6. May 1, 2019

    Granted

    Published in Swissreg on 01.05.2019

Parties

Holder

XOMA (US) LLC

2910 Seventh Street, Berkeley, CA 94710, US

Inventor

WHITE, Mark Leslie

Berkeley, CA 94710, US

BHASKAR, Vinay

Berkeley, CA 94710, US

WATSON, Susan R.

Berkeley, CA 94710, US

CORBIN, John

Berkeley, CA 94710, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.